Genmab A (GMAB) Assets Average (2019 - 2026)

Genmab A has reported Assets Average for 5 years, with the latest figure at $12.6 billion in Q1 2026.

• For the quarter ending Q1 2026, Assets Average rose 30.91% year-over-year to $12.6 billion; the trailing twelve-month figure through Mar 2026 stood at $12.6 billion (up 30.91% YoY), and the FY2025 full-year result was $9.7 billion, changed N/A from the prior year.
• Assets Average for Q1 2026 stood at $12.6 billion, up from $9.9 billion in the prior quarter.
• The five-year high for Assets Average was $12.6 billion in Q1 2026, with the low at $5.6 billion in Q3 2024.
• Historically, Assets Average has averaged $8.6 billion across 3 years, with a median of $9.6 billion in 2025.
• The largest YoY upside for Assets Average was 60.84% in 2025 against a maximum downside of 20.54% in 2025.
• Genmab A's Assets Average stood at $6.2 billion in 2024, then jumped by 60.84% to $9.9 billion in 2025, then climbed by 26.92% to $12.6 billion in 2026.
• The last three Assets Average figures came in at $12.6 billion (Q1 2026), $9.9 billion (Q4 2025), and $6.7 billion (Q3 2025), per Business Quant data.